Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Market indexes were looking like they might fall into the red this afternoon, a half hour before the closing bell, based on news from the White House that +25% tariffs were being set on our ...

BellRing Brands (BRBR) closed the most recent trading day at $79.39, moving +1.39% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.53%. Meanwhile, the Dow gained 0.

The tech-driven Nasdaq 100 may be undergoing a historic shift as it turns 40 this week. According to Strategas Securities' Todd Sohn, cryptocurrency companies could fuel the next wave of gains.

Atlassian Corp Plc (NASDAQ:TEAM) reported its fourth-quarter 2024 earnings, significantly surpassing market expectations with an EPS of $0.96 against a forecast of $0.62. The company also exceeded ...

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) rose 3% in post-market trading Thursday on news the company had received FDA ...